The rapid onset of COVID-19 in the United States, combined with the dismantling of the spring 2020 medical conference infrastructure and widespread travel bans and social distancing has created a synchronous need in all clinical arenas to manage patients with pre-existing conditions, such as schizophrenia, who require management with LAIs, with little to no ability for traditional scientific meeting, and smaller meetings to share experiences and insights.
This curriculum is designed as a multi-component educational series with three webinars that cover antipsychotic mechanisms of action, LAIs and the evidence for improved care, techniques on LAI administration, and strategies for employing optimal interaction with patients who have schizophrenia during the public health emergency of COVID-19. These webinars are targeted to, and accredited for, physicians, pharmacists, nurse practitioners, and nurses.
Sign in to register for all FREE!